会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COMPOSITIONS AND DRUG-DELIVERY SYSTEMS COMPRISING RAPAMYCIN ANALOGS AND PACLITAXEL
    • 包含RAPAMYCIN类似物和PACLITAXEL的组合物和药物递送系统
    • WO2008021124A3
    • 2008-04-03
    • PCT/US2007017619
    • 2007-08-07
    • ABBOTT LABBURKE SANDRA ECROMACK KEITH RMACK MATTHEWTONER JOHN L
    • BURKE SANDRA ECROMACK KEITH RMACK MATTHEWTONER JOHN L
    • A61K45/06A61K9/127A61L31/14A61L31/16A61P7/10
    • A61K45/06A61K9/0019A61K9/0024A61K31/337A61K31/4745A61L31/16A61L2300/416A61L2300/45
    • The present invention provides for drug-delivery systems and compositions comprising zotarolimus and paclitaxel, or derivatives, prodrugs or salts thereof, as well as methods of treatment using such systems and compositions, wherein the drugs complement each other in effect and/or activity. Medical devices are disclosed which include supporting structures that include at least one pharmaceutically acceptable carrier or excipient, which carrier or excipient can include one or more therapeutic agents or substances, with the carrier including at least one coating on the surface thereof, and the coating associated with the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and drug-delivery systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
    • 本发明提供药物递送系统和组合物,其包含唑他罗莫司和紫杉醇或其衍生物,前药或盐,以及使用这种系统和组合物的治疗方法,其中所述药物在有效和/或活性中相互补充。 公开了包括至少一种药学上可接受的载体或赋形剂的载体结构的医疗装置,所述载体或赋形剂可以包括一种或多种治疗剂或物质,载体包括其表面上的至少一个涂层,并且涂层相关联 与治疗物质,例如药物。 适用于本发明的医疗装置的支撑结构包括但不限于冠状支架,外周支架,导管,动静脉移植物,旁路移植物和用于脉管系统的药物递送球囊。 这些组合物和药物递送系统可以与其它药物组合使用,包括抗增殖剂,抗血小板剂,抗炎剂,抗血栓形成剂,细胞毒性药物,抑制细胞因子或趋化因子结合的药物 分化抑制剂,抗脂血症药,基质金属蛋白酶抑制剂,细胞抑制药物或这些和其他药物的组合。
    • 3. 发明申请
    • COMPOSITIONS AND METHODS OF ADMINISTERING RAPAMYCIN ANALOGS WITH PACLITAXEL USING MEDICAL DEVICES
    • 使用医疗设备管理吡虫啉类似物的组合物和方法
    • WO2008045961A3
    • 2008-08-28
    • PCT/US2007080987
    • 2007-10-10
    • ABBOTT LABTONER JOHN LBURKE SANDRA ECROMACK KEITH RMACK MATTHEW
    • TONER JOHN LBURKE SANDRA ECROMACK KEITH RMACK MATTHEW
    • A61K31/37A61K31/436A61P9/00
    • A61K31/337A61K9/0024A61K31/436A61L31/10A61L31/16A61L2300/416A61L2300/45C07D498/18
    • Systems and compositions comprising paclitaxel and a second drug, such as rapamycin, analogs, derivatives, salts and esters thereof are disclosed, as well as methods of delivery wherein the drugs have effects that complement each other. Medical devices comprising supporting structures capable of including or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient can contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating including the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
    • 公开了包含紫杉醇和第二药物如雷帕霉素,类似物,衍生物,盐和酯的系统和组合物,以及其中药物具有互补作用的递送方法。 包含能够包含或支持药学上可接受的载体或赋形剂的支持结构的医疗装置,所述载体或赋形剂可以含有一种或多种治疗剂或物质,所述载体优选在其表面上包括涂层,所述包衣包括治疗物质 ,例如药物。 适用于本发明的医疗装置的支撑结构包括冠状支架,外周支架,导管,动静脉移植物,旁路移植物和用于脉管系统中的药物递送球囊。 这些组合物和系统可以与其它药物组合使用,包括抗增殖剂,抗血小板剂,抗炎剂,抗血栓形成剂,细胞毒性药物,抑制细胞因子或趋化因子结合的药物,细胞去分化抑制剂 ,抗脂血症药,基质金属蛋白酶抑制剂,细胞抑制药物或这些和其他药物的组合。
    • 4. 发明申请
    • ZOTAROLIMUS-CONTAINING DRUG DELIVERY SYSTEMS FOR IMPLANTATION INTO A BODY LUMEN OF A SUBJECT
    • 含ZOTAROLIMUS的药物输送系统,用于植入身体的身体
    • WO2007111925A3
    • 2007-11-15
    • PCT/US2007007090
    • 2007-03-21
    • ABBOTT LABTONER JOHN LBURKE SANDRA ECROMACK KEITH R
    • TONER JOHN LBURKE SANDRA ECROMACK KEITH R
    • A61K9/00A61F2/06A61K31/00A61L27/00A61L29/00A61L31/16
    • A61K9/0019A61F2/91A61K31/192A61K31/4745A61L31/10A61L31/16A61L2300/256A61L2300/41A61L2300/416A61L2300/42A61L2300/45A61L2300/602
    • Systems and compositions comprising zotarolimus that are safer, more effective and produce less inflammation than rapamycin and paclitaxel systems are disclosed. Medical devices comprising supporting structures capable of containing or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient can contain one or more therapeutic agents or substances, with the carrier including a coating on the surface thereof, and the coating having the therapeutic compounds, including, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
    • 公开了包含佐他莫司的系统和组合物,其比雷帕霉素和紫杉醇系统更安全,更有效并且产生较少的炎症。 医疗装置包括能够包含或支持药学上可接受的载体或赋形剂的载体结构的载体或赋形剂,所述载体或赋形剂可以包含一种或多种治疗剂或物质,载体包括其表面上的涂层,以及具有治疗化合物的涂层, 包括例如药物。 适用于本发明的医疗装置的支撑结构包括冠状支架,外周支架,导管,动静脉移植物,旁路移植物和用于脉管系统中的药物递送球囊。 这些组合物和系统可以与其它药物组合使用,包括抗增殖剂,抗血小板剂,抗炎剂,抗血栓形成剂,细胞毒性药物,抑制细胞因子或趋化因子结合的药物,细胞去分化抑制剂 ,抗脂血症药,基质金属蛋白酶抑制剂,细胞抑制药物或这些和其他药物的组合。
    • 5. 发明申请
    • METHODS OF ADMINISTERING RAPAMYCIN ANALOGS WITH ANTI-INFLAMMATORIES USING MEDICAL DEVICES
    • 用抗肿瘤药物治疗RAPAMYCIN类似物的方法
    • WO2008063319A3
    • 2009-04-30
    • PCT/US2007021846
    • 2007-10-12
    • ABBOTT LABTONER JOHN LBURKE SANDRA ECROMACK KEITH RMACK MATTHEW
    • TONER JOHN LBURKE SANDRA ECROMACK KEITH RMACK MATTHEW
    • A61L31/16
    • A61L31/16A61F2/91A61F2250/0067A61L2300/416A61L2300/45
    • A medical device comprising a supporting structure capable of including or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may include one or more therapeutic agents or substances, with the carrier including a coating on the surface thereof, and the coating including the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to. This drug can be used in combination with another drug including those selected from anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these drugs.
    • 一种医疗装置,其包括能够包含或支撑药学上可接受的载体或赋形剂的支持结构,所述载体或赋形剂可以包含一种或多种治疗剂或物质,所述载体在其表面上包括涂层,并且所述包衣包含治疗 物质,例如药物。 适用于本发明的医疗装置的支撑结构包括但不限于冠状支架,外周支架,导管,动静脉移植物,旁路移植物和用于脉管系统中的药物递送球囊。 适用于本发明的药物包括但不限于此。 该药物可以与另一种药物组合使用,包括选自抗增殖剂,抗血小板剂,抗炎剂,抗血栓形成剂,细胞毒性药物,抑制细胞因子或趋化因子结合的药物,细胞去分化抑制剂 ,抗脂血症药,基质金属蛋白酶抑制剂,细胞抑制药物或这些药物的组合。
    • 6. 发明申请
    • METHODS OF ADMINISTERING RAPAMYCIN ANALOGS WITH ANTI-INFLAMMATORIES USING MEDICAL DEVICES
    • 用抗肿瘤药物治疗RAPAMYCIN类似物的方法
    • WO2007047473A3
    • 2007-08-09
    • PCT/US2006040155
    • 2006-10-12
    • ABBOTT LABTONER JOHN LBURKE SANDRA ECROMACK KEITH RMACK MATTHEW
    • TONER JOHN LBURKE SANDRA ECROMACK KEITH RMACK MATTHEW
    • A61F2/00A61K31/44
    • A61L31/16A61K31/192A61K31/4745A61L27/34A61L27/54A61L29/085A61L29/16A61L31/10A61L2300/256A61L2300/416
    • A medical device comprising a supporting structure capable of including or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may include one or more therapeutic agents or substances, with the carrier including a coating on its surface, and the coating including the therapeutic substances, such as, for example, drugs. Supporting structures suitable for use include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to, This drug can be used in combination with another drug including those selected from anti-proliferative, anti-platelet, anti-inflammatory and anti-thrombotic agents; cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these drugs.
    • 一种医疗装置,包括能够包含或支持药学上可接受的载体或赋形剂的载体或赋形剂,所述载体或赋形剂可以包括一种或多种治疗剂或物质,所述载体包括其表面上的涂层,所述涂层包括治疗物质 ,例如药物。 适合使用的支撑结构包括但不限于冠状动脉支架,外周支架,导管,动静脉移植物,旁路移植物和用于脉管系统的药物递送球囊。 适用于本发明的药物包括但不限于:该药物可与包括选自抗增殖,抗血小板,抗炎和抗血栓形成剂的那些药物组合使用。 细胞毒性药物,抑制细胞因子或趋化因子结合的药物,细胞去分化抑制剂,抗脂血症药,基质金属蛋白酶抑制剂,细胞抑制药物或这些药物的组合。
    • 7. 发明申请
    • COMPOSITIONS, SYSTEMS, KITS, AND METHODS OF ADMINISTERING RAPAMYCIN ANALOGS WITH PACLITAXEL USING MEDICAL DEVICES
    • 使用医疗设备用紫杉醇施用雷帕霉素类似物的组合物,系统,试剂盒和方法
    • WO2007046935A3
    • 2007-07-05
    • PCT/US2006031879
    • 2006-08-15
    • ABBOTT LABBURKE SANDRA ECROMACK KEITH RMACK MATTHEWTONER JOHN L
    • BURKE SANDRA ECROMACK KEITH RMACK MATTHEWTONER JOHN L
    • A61F6/06
    • A61L31/16A61K31/192A61K31/4745A61L27/34A61L27/54A61L29/085A61L29/16A61L31/10A61L2300/256A61L2300/416
    • A system and compositions including zotarolimus and paditaxel are disclosed, as well as methods of delivery, wherein the drugs have effects that complement each other. Medical devices are disclosed which include supporting structures that include at least one pharmaceutically acceptable carrier or excipient, which carrier or excipient can include one or more therapeutic agents or substances, with the carrier including at least one coating on the surface thereof, and the coating associated with the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including antiproliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de- differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
    • 公开了一种包含佐他莫司和紫杉醇的系统和组合物,以及递送方法,其中所述药物具有彼此互补的作用。 公开了包括支撑结构的医疗装置,所述支撑结构包括至少一种药学上可接受的载体或赋形剂,所述载体或赋形剂可以包括一种或多种治疗剂或物质,其中所述载体在其表面上包含至少一个涂层, 与治疗物质,例如药物一起使用。 适用于本发明的医疗装置的支撑结构包括但不限于冠状动脉支架,外周支架,导管,动脉 - 静脉移植物,旁路移植物和脉管系统中使用的药物递送球囊。 这些组合物和系统可以与其他药物组合使用,包括抗增殖剂,抗血小板剂,抗炎剂,抗血栓形成剂,细胞毒性药物,抑制细胞因子或趋化因子结合的药剂,细胞去分化抑制剂,抗 血压药,基质金属蛋白酶抑制剂,细胞生长抑制药或这些与其他药物的组合。
    • 10. 发明申请
    • COMPOSITIONS AND METHODS OF ADMINISTERING RAPAMYCIN ANALOGS WITH PACLITAXEL USING MEDICAL DEVICES
    • 使用医疗设备用紫杉醇施用雷帕霉素类似物的组合物和方法
    • WO2007047416A3
    • 2007-11-08
    • PCT/US2006040027
    • 2006-10-12
    • ABBOTT LABBURKE SANDRA ECROMACK KEITH RMACK MATTHEWTONER JOHN L
    • BURKE SANDRA ECROMACK KEITH RMACK MATTHEWTONER JOHN L
    • A61F2/00A61K31/44
    • A61L31/16A61K31/192A61K31/4745A61L27/34A61L27/54A61L29/085A61L29/16A61L31/10A61L2300/256A61L2300/416
    • Systems and compositions comprising paclitaxel and a second drug, such as rapamycin, analogs, derivatives, salts and esters thereof are disclosed, as well as methods of delivery wherein the drugs have effects that complement each other. Medical devices comprising supporting structures capable of including or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient can contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating including the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
    • 公开了包含紫杉醇和第二种药物如雷帕霉素,其类似物,衍生物,盐和酯的系统和组合物,以及其中药物具有互补作用的递送方法。 包含能够包含或承载药学上可接受的载体或赋形剂的载体结构的医疗器械,该载体或赋形剂可以含有一种或多种治疗剂或物质,载体优选在其表面上包含涂层,并且包含治疗物质 ,例如药物。 适用于本发明的医疗装置的支撑结构包括冠状动脉支架,外周支架,导管,动脉 - 静脉移植物,旁路移植物和脉管系统中使用的药物递送球囊。 这些组合物和系统可以与其他药物组合使用,包括抗增殖剂,抗血小板剂,抗炎剂,抗血栓形成剂,细胞毒性药物,抑制细胞因子或趋化因子结合的药剂,细胞去分化抑制剂 ,抗血液流变剂,基质金属蛋白酶抑制剂,细胞抑制药物或这些与其他药物的组合。